Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

901 pLNCX myr HA Akt1 Citations (19)

Originally described in: Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR Proc Natl Acad Sci U S A. 1999 Mar 2. 96(5):2110-5.
PubMed Journal

Articles Citing 901 pLNCX myr HA Akt1

Articles
AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Pan JQ, Lewis MC, Ketterman JK, Clore EL, Riley M, Richards KR, Berry-Scott E, Liu X, Wagner FF, Holson EB, Neve RL, Biechele TL, Moon RT, Scolnick EM, Petryshen TL, Haggarty SJ. Neuropsychopharmacology. 2011 Jun;36(7):1397-411. doi: 10.1038/npp.2011.24. Epub 2011 Mar 9. PubMed
A modelling-experimental approach reveals insulin receptor substrate (IRS)-dependent regulation of adenosine monosphosphate-dependent kinase (AMPK) by insulin. Sonntag AG, Dalle Pezze P, Shanley DP, Thedieck K. FEBS J. 2012 Sep;279(18):3314-28. doi: 10.1111/j.1742-4658.2012.08582.x. Epub 2012 May 3. PubMed
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner. Gagliardi PA, di Blasio L, Orso F, Seano G, Sessa R, Taverna D, Bussolino F, Primo L. Neoplasia. 2012 Aug;14(8):719-31. PubMed
Transformation of human ovarian surface epithelial cells by Kruppel-like factor 8. Lu H, Wang X, Urvalek AM, Li T, Xie H, Yu L, Zhao J. Oncogene. 2014 Jan 2;33(1):10-8. doi: 10.1038/onc.2012.545. Epub 2012 Dec 10. PubMed
Pathogen signatures activate a ubiquitination pathway that modulates the function of the metabolic checkpoint kinase mTOR. Ivanov SS, Roy CR. Nat Immunol. 2013 Dec;14(12):1219-28. doi: 10.1038/ni.2740. Epub 2013 Oct 13. PubMed
Role of phosphatidylinositol 3-kinase (PI3K) and Akt1 kinase in porcine reproductive and respiratory syndrome virus (PRRSV) replication. Wang X, Zhang H, Abel AM, Young AJ, Xie L, Xie Z. Arch Virol. 2014 Aug;159(8):2091-6. doi: 10.1007/s00705-014-2016-4. Epub 2014 Feb 18. PubMed
LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation. Tworkoski K, Raab-Traub N. J Virol. 2015 Mar;89(5):2590-602. doi: 10.1128/JVI.02921-14. Epub 2014 Dec 17. PubMed
SEC14L2 enables pan-genotype HCV replication in cell culture. Saeed M, Andreo U, Chung HY, Espiritu C, Branch AD, Silva JM, Rice CM. Nature. 2015 Aug 27;524(7566):471-5. doi: 10.1038/nature14899. Epub 2015 Aug 12. PubMed
Over-expressing Akt in T cells to resist tumor immunosuppression and increase anti-tumor activity. Wu Y, Deng Z, Tang Y, Zhang S, Zhang YQ. BMC Cancer. 2015 Aug 27;15:603. doi: 10.1186/s12885-015-1611-4. PubMed
SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway. Quan Y, Wang N, Chen Q, Xu J, Cheng W, Di M, Xia W, Gao WQ. Oncotarget. 2015 Sep 22;6(28):26494-507. doi: 10.18632/oncotarget.4764. PubMed
Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation. Yamaguchi K, Takanashi T, Nasu K, Tamai K, Mochizuki M, Satoh I, Ine S, Sasaki O, Satoh K, Tanaka N, Harigae H, Sugamura K. Cancer Sci. 2016 May;107(5):638-43. doi: 10.1111/cas.12921. Epub 2016 Apr 7. PubMed
Autophagy induction by SIRT6 is involved in oxidative stress-induced neuronal damage. Shao J, Yang X, Liu T, Zhang T, Xie QR, Xia W. Protein Cell. 2016 Apr;7(4):281-90. doi: 10.1007/s13238-016-0257-6. Epub 2016 Mar 16. PubMed
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells. Bosch-Vilaro A, Jacobs B, Pomella V, Abbasi Asbagh L, Kirkland R, Michel J, Singh S, Liu X, Kim P, Weitsman G, Barber PR, Vojnovic B, Ng T, Tejpar S. Oncotarget. 2017 Jan 17;8(3):4277-4288. doi: 10.18632/oncotarget.13834. PubMed
Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle. Wasson CW, Morgan EL, Muller M, Ross RL, Hartley M, Roberts S, Macdonald A. Oncotarget. 2017 Oct 6;8(61):103581-103600. doi: 10.18632/oncotarget.21658. eCollection 2017 Nov 28. PubMed
Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase. Gwinn DM, Lee AG, Briones-Martin-Del-Campo M, Conn CS, Simpson DR, Scott AI, Le A, Cowan TM, Ruggero D, Sweet-Cordero EA. Cancer Cell. 2018 Jan 8;33(1):91-107.e6. doi: 10.1016/j.ccell.2017.12.003. PubMed
Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis. Hogstrand K, Darmanin S, Forshell TP, Grandien A. Oncotarget. 2018 Apr 20;9(30):21396-21410. doi: 10.18632/oncotarget.25113. eCollection 2018 Apr 20. PubMed
Akt Regulates a Rab11-Effector Switch Required for Ciliogenesis. Walia V, Cuenca A, Vetter M, Insinna C, Perera S, Lu Q, Ritt DA, Semler E, Specht S, Stauffer J, Morrison DK, Lorentzen E, Westlake CJ. Dev Cell. 2019 Jul 22;50(2):229-246.e7. doi: 10.1016/j.devcel.2019.05.022. Epub 2019 Jun 13. PubMed
Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells. Singh D, Mohapatra P, Kumar S, Behera S, Dixit A, Sahoo SK. Toxicol In Vitro. 2022 Mar;79:105293. doi: 10.1016/j.tiv.2021.105293. Epub 2021 Dec 6. PubMed
CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis. Mohapatra P, Mohanty S, Ansari SA, Shriwas O, Ghosh A, Rath R, Majumdar SKD, Swain RK, Raghav SK, Dash R. FASEB J. 2022 Oct;36(10):e22566. doi: 10.1096/fj.202200808RR. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.